Viracta Therapeutics
San Diego, US
Biotech
Founders & leadership
IR
Ivor RoystonExecutive Officer, Director
RG
Richard GhalieDirector
JW
James WoodyDirector
PS
Patrick Soon-ShiongDirector
DS
David SlackExecutive Officer
Reported raises · per SEC filings
Form D private placements$65MraisedMar 2021 · 26 investors · Biotechnology
Rule 506(b)$40MraisedDec 2020 · 14 investors · Biotechnology
Rule 506(b)$16.8MraisedNov 2019 · 21 investors · Biotechnology
Rule 506(b)$5.7MraisedFeb 2019 · 25 investors · Biotechnology
Rule 506(b)$10.7MraisedFeb 2019 · 6 investors · Biotechnology
Rule 506(b)$2.7MraisedJul 2018 · 27 investors · Biotechnology
Rule 506(b)$9.9MraisedApr 2017 · 9 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.